Nutritional Impacts of Cancer Treatment: Head and Neck & Breast Cancers (Week 7 Lecture 2) Flashcards

1
Q

How does muscle loss differ in cancer types?

A

Muscle loss differs by disease site and treatment plan
* taxane based therapy almost no loss compared to pancreatic
* important to know where it is and what the treatment plan is, changes what happens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Overview of head & neck cancers

A

essentially from bottom of neck to around nose
* Mostly stage III and IV at diagnosis
* Risk factors: smoking, alcohol, wood & chemical exposure, Epstein-Barr Virus, HPV (part of why there is currently a spike, but hopefully HPV will be reduced with vaccines but many 50 year olds did not get vaccinated as kids)
* Oral and oropharynx – increased incidence due to HPV
* Can have delay if lump in throat and thinking its just a cold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is head and neck cancer treated?

A

Surgery: with skin grafts, extra nutrition would be needed for healing
radiotherapy: radiation has mask made to hold on table and beam must go precisely where it needs to go. treatment is like a full time job; 30 min a day 5 days a week , intensive but not too much time
chemotherapy: Platin-based therapy weekly dose 7 days a week and may make mouth taste like muscle and normal cells that turnover quickly get hurt too like GI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Prevalence and prognostic significance of malnutrition in patients with cancer of the head and neck

A

Shows risk of loss, depending on where you were to start
* 3 means weight loss really needs to be addressed and 4 is very bad, likely to die quickly
* With BMI over 28, if you have even over 6% it gets dangerous too

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is weight loss grade associated with survival?

A

associated with reduced survival
* WL grade 1 is 50% greater chance of death
* WL grade 4 is huge, 164% higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acute nutrition impacts of surgery

A
  • Inability to eat or drink orally after surgery (unless surgery really small)
  • Recovery from skin grafts
  • Psychosocial impacts, loss of voice, loss of income
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acute nutrition impact of Radiation +/- Chemotherapy

A
  • multi-symptom assessment and management is required
  • many symptoms persist for 6-12 weeks after treatment, or longer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Head and Neck Symptom Checklist

A

An instrument to evaluate nutrition impact symptoms effect on energy intake and weight loss., Supportive Care in Cancer for head and neck patients which allows patients to say how long they have had symptoms and whether it is a problem for eating
* similar to SGA
* odenophagia: oral pain
* xerostomia: dry mouth
* anorexia: loss of appetite
* feeling full/ early satiety
* dysphagia: difficulty swallowing
* mucositosis (mostly oral but can also go throughout GI)
* dysguesia (taste changes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When does toxicity effects of radiation therapy peak?

A

most prevalent part peaks at week 7 because towards end of therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nutrition management for Dry mouth/ thick saliva +/- oral thrush

A

medical strategies
* xylitol tablets (promotes salivation, but only works if salivary gland is still around
* lemon drops (may cause dooth decay)
* oral rinsings, sprays

Food strategies (difficult to taste without saliva)
* fruits based smoothies (better than chocolate or vanilla because of acidity)
* soup/ stew
* soft pasta ++ sauce

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nutrition management for oral pain

A

medical strategies
* opioids - often lots of liquid morphine which some dont want but that often changes within a week. constipation and feeling full is side effect

Food strategies
* soft/ moist foods
* fruit sauces
* fluids (ONS, milk, ice cream, sorbet)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nutrition management for chew/swallow difficulty, aspiration

A

medical intervention
* thickened liquids of required for safety

food strategies
* purees
* enteral nutrition (usually for fluids)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Nutrition management for taste changes

A
  • nutrition counseling related to coping/ framing
  • FASS (fat, acid, salty, sweet)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe FASS

A

Using fat acid salt and sweet to manage taste changes
* following the line may provide quick fixes on how to make a food taste better if there is too much of one taste or another (problem though if trouble cooking meals)
*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

factors that increase risk for breast cancer

A
  • any amount of alcohol (pre- and post-menopausal BC)
  • excess body fat (post-menopausal BC)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Factors that decrease risk for breast cancer

A
  • vigorous physical activity (probably linked to lower adiposity)
  • decreased adiposity
  • lactation
17
Q

What can impact breast cancer treatment plan?

A

Hormone receptor status impacts treatment plan (firs thing to look at)
* Estrogen receptor (ER), progesterone receptor (PR), HER2 positive/negative
* Triple-negative: ~15% of all cases
* These values determine treatment plan

18
Q

How is breast cancer treated?

A
  • radiation doesnt really impact nutrition too much due to area
  • neoadjuvent: chemo given before surgery to shrink tumour
  • adjuvant: given chemo given after surgery in order to decrease risk of reoccurence
  • palliative-intent: When patient cannot have surgery or has resurgence and is metastatic so still being treated to try and reduce growth, but is not to cure
19
Q

Acute impacts from breast cancer treatment

A
  • Surgery: Reduced exercise due to fatigue, pain, lymphedema
  • Radiation therapy: Few nutritional impacts if protein is adequate
  • Hormone therapy: menopause-like symptoms; bone mineral density loss
  • Chemotherapy/targeted therapy: Nutrition status can weaken throughout treatment (Anorexia, nausea, fatigue); Metastatic disease (anorexia +/- cachexia); Diarrhea, gut alterations
  • Adipose gain, muscle loss is common throughout this journey (too tired to exercise)
20
Q

nutrition management for breast cancer

A
  • Confusion, fear of food, restrictive diets: Myth-busting, breast-cancer specific nutrition education, supportive listening, educate the team
  • Increased adiposity: Group fitness classes, resistance training, adequate protein
  • Bone mineral density loss: Protein, calcium, vitamin D, weight-bearing exercise (Ca and vit D supplement reccomended)
21
Q

Breast cancer in the long term

A
  • 90% of women with breast cancer survive 5 years
  • Post-treatment motivation to change lifestyle is often high
  • Muscle loss and adipose gain impact survivorship
  • Counsel survivors to: avoid alcohol, reduce body fat. increase muscle mass with resistance training, engage in regular vigorous physical activity
22
Q

Body composition & treatment toxicity in breast cancer

A
  • Sarcopenia: link between low muscle mass and chemo dose in breast cancer which is based on body surface area. So if people are larger but low muscle mass may get overdose of chemo and toxicity occurs.
  • sarcopenia + obesity: sarcopenia obesity in breast cancer = highest risk of grade 3-4 toxiciy
  • fat mass: higher absolute fat mass but not BMI or BSA associated with higher risk of toxicity-induced treatment modifications
23
Q

what is current reccomendations for chemo dosing based on body composition?

A

current state of reccomendations is still to give the full dose because we dont know if its muscle, sarcopenia and adiposity, or fat mass that is the factor to look at
* Reinforces ASCO 2012 recommendations for full weight-based dosing in obesity.
* Acknowledges the potential impact of sarcopenic obesity but cites lack of clear evidence from prospective studies.